NATO AMEDP-7.5 PDF

This document includes information necessary to estimate acute human response to a specific set of CBRN agents and effects. This set is not exhaustive, and other agents or effects could be incorporated at a later time as permitted by the availability of adequate, credible data to enable model development.

PURPOSE AND INTENDED USE

1. The purpose of this document is to describe a methodology for estimating casualties uniquely occurring as a consequence of CBRN incidents near Allied forces, in support of the planning processes described in Allied Joint Publication 3.8 (AJP- 3.8), Allied Joint Doctrine for NBC Defence,² Allied Joint Publication 4.10 (AJP-4.10), Allied Joint Medical Support Doctrine,³ Allied Joint Medical Publication 1 (AJMedP- 1), Allied Joint Medical Planning Doctrine,⁴ Allied Joint Medical Publication 7 (AJMedP-7), Allied Joint Medical Doctrine for Support to CBRN Defensive Operations,⁵ and Allied Medical Publication 7.6 (AMedP-7.6), Commander’s Guide to Medical Support in Chemical, Biological, Radiological, and Nuclear Environments.⁶

2. The purpose of themethodology is to estimate the number, type, severity, and timing of CBRN casualties.

3. The purpose of CBRN casualty estimates is to assist planners, logisticians, and other staff officers in quantifying contingency requirements for medical force structure, specialty personnel, medical materiel, and patient transport or evacuation. Some example users and how they might use the output are:

a. Operational planners may use CBRN casualty estimates to provide coordinating instructions to units or to assess unit casualty distributions when evaluating Courses of Action resulting from variations in a number of parameters, such as availability of medical countermeasures (e.g. prophylaxis). Allied Joint Publication 5 (AJP-5), Allied Joint Doctrine for Operational-Level Planning,⁷ provides information for operational planners.

b. Logistics planners may use CBRN casualty estimates to determine logistical requirements, both medical and non-medical, for the management of CBRN casualties. Allied Joint Publication 4 (AJP-4), Allied Joint Logistic Doctrine,⁸ provides information for logistics planners.

c. Personnel planners may use CBRN casualty estimates to plan for personnel replacements.

d. Medical planners may use CBRN casualty estimates to identify medical resource requirements, such as pharmaceuticals, medical devices, medical supplies, bed types, and personnel specialties, for each role of medical treatment. Commanders, Medical Advisors, and Medical Directors may also use casualty estimates to evaluate medical courses of action. AMedP-7.6 and AJP-4.10 provide further information about planning for medical operations in CBRN environments.

4. The methodology described herein is of such complexity that it will be very difficult to execute it without a software-based implementation. Accordingly, the methodology is proposed solely for deliberate planning and is not intended for realtime use. Moreover, it is not intended for use in deployment health surveillance or for any post-incident uses including diagnosis, medical treatment, or epidemiology.

5. It is recommended that when this document is printed, it should be printed in color. There are many figures that use color to help visually convey information.

² North Atlantic Treaty Organization (NATO), AJP-3.8(A): Allied Joint Doctrine for CBRN Defence, STANAG 2451 (Brussels, Belgium: NATO, March 2012).

³ North Atlantic Treaty Organization (NATO), AJP-4.10(B): Allied Joint Medical Support Doctrine, STANAG 2228 (Brussels, Belgium: NATO, May 2015).

⁴ North Atlantic Treaty Organization (NATO), AJMedP-1: Allied Joint Medical Planning Doctrine, STANAG 2542 (Brussels, Belgium: NATO, November 2009).

⁵ North Atlantic Treaty Organization (NATO), AJMedP-7: Allied Joint Medical Doctrine for Support to Chemical, Biological, Radiological, and Nuclear (CBRN) Defensive Operations, STANAG 2596 (Brussels, Belgium: NATO, August 2015).

⁶ North Atlantic Treaty Organization (NATO), AMedP-7.6: Commander's Guide on Medical Support to Chemical, Biological, Radiological, and Nuclear (CBRN) Defensive Operations, STANAG 2873 (Brussels, Belgium: NATO, study).

⁷ North Atlantic Treaty Organization (NATO), AJP-5: Allied Joint Doctrine for Operational-Level Planning, STANAG 2526 (Brussels, Belgium: NATO, June 2013).

⁸ North Atlantic Treaty Organization (NATO), AJP-4(A): Allied Joint Logistics Doctrine, STANAG 2182 (Brussels, Belgium: NATO, March 2004).